179 related articles for article (PubMed ID: 15910497)
1. Early development of primary biliary cirrhosis in female C57BL/6 mice because of poly I:C administration.
Okada C; Akbar SM; Horiike N; Onji M
Liver Int; 2005 Jun; 25(3):595-603. PubMed ID: 15910497
[TBL] [Abstract][Full Text] [Related]
2. Ae2a,b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis.
Salas JT; Banales JM; Sarvide S; Recalde S; Ferrer A; Uriarte I; Oude Elferink RP; Prieto J; Medina JF
Gastroenterology; 2008 May; 134(5):1482-93. PubMed ID: 18471521
[TBL] [Abstract][Full Text] [Related]
3. Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis.
Liu B; Shi XH; Zhang FC; Zhang W; Gao LX
Liver Int; 2008 Feb; 28(2):233-9. PubMed ID: 18251980
[TBL] [Abstract][Full Text] [Related]
4. The multi-hit hypothesis of primary biliary cirrhosis: polyinosinic-polycytidylic acid (poly I:C) and murine autoimmune cholangitis.
Ambrosini YM; Yang GX; Zhang W; Tsuda M; Shu S; Tsuneyama K; Leung PS; Ansari AA; Coppel RL; Gershwin ME
Clin Exp Immunol; 2011 Oct; 166(1):110-20. PubMed ID: 21910728
[TBL] [Abstract][Full Text] [Related]
5. Breakdown of tolerance to pyruvate dehydrogenase complex in experimental autoimmune cholangitis: a mouse model of primary biliary cirrhosis.
Jones DE; Palmer JM; Yeaman SJ; Kirby JA; Bassendine MF
Hepatology; 1999 Jul; 30(1):65-70. PubMed ID: 10385640
[TBL] [Abstract][Full Text] [Related]
6. Nonsuppurative cholangitis is induced in neonatally thymectomized mice: a possible animal model for primary biliary cirrhosis.
Kobashi H; Yamamoto K; Yoshioka T; Tomita M; Tsuji T
Hepatology; 1994 Jun; 19(6):1424-30. PubMed ID: 8188172
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic value of anti-mitochondrial antibodies, especially in primary biliary cirrhosis.
Tanaka A; Miyakawa H; Luketic VA; Kaplan M; Storch WB; Gershwin ME
Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):295-9. PubMed ID: 12030434
[TBL] [Abstract][Full Text] [Related]
8. Antimitochondrial antibody-negative primary biliary cirrhosis.
Mendes F; Lindor KD
Gastroenterol Clin North Am; 2008 Jun; 37(2):479-84, viii. PubMed ID: 18499032
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of immune disturbances and chronic liver disease in family members of patients with primary biliary cirrhosis.
Bittencourt PL; Farias AQ; Abrantes-Lemos CP; Goncalves LL; Goncalves PL; Magalhães EP; Carrilho FJ; Laudanna AA; Cançado EL
J Gastroenterol Hepatol; 2004 Aug; 19(8):873-8. PubMed ID: 15242489
[TBL] [Abstract][Full Text] [Related]
10. [Establishment of a mouse model of primary biliary cirrhosis by AMA M2 autoantigen injection].
Jiang XH; Zhong RQ; Fang XY; An F; Hu Y; Wang XP; Kong XT
Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):202-4. PubMed ID: 16556416
[TBL] [Abstract][Full Text] [Related]
11. Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanism.
Wang J; Sun R; Wei H; Dong Z; Gao B; Tian Z
J Hepatol; 2006 Mar; 44(3):446-54. PubMed ID: 16310275
[TBL] [Abstract][Full Text] [Related]
12. IL-2 receptor alpha(-/-) mice and the development of primary biliary cirrhosis.
Wakabayashi K; Lian ZX; Moritoki Y; Lan RY; Tsuneyama K; Chuang YH; Yang GX; Ridgway W; Ueno Y; Ansari AA; Coppel RL; Mackay IR; Gershwin ME
Hepatology; 2006 Nov; 44(5):1240-9. PubMed ID: 17058261
[TBL] [Abstract][Full Text] [Related]
13. Does the diagnosis of primary biliary cirrhosis or autoimmune cholangitis depend on the 'phase' of the disease?
Kadokawa Y; Omagari K; Ohba K; Masuda J; Hazama H; Kinoshita H; Ohnita K; Mizuta Y; Tanioka H; Imanishi T; Kohno S
Liver Int; 2005 Apr; 25(2):317-24. PubMed ID: 15780056
[TBL] [Abstract][Full Text] [Related]
14. The clinical significance of IgA antimitochondrial antibodies in sera and saliva in primary biliary cirrhosis.
Tanaka A; Nezu S; Uegaki S; Mikami M; Okuyama S; Kawamura N; Aiso M; Gershwin ME; Takahashi S; Selmi C; Takikawa H
Ann N Y Acad Sci; 2007 Jun; 1107():259-70. PubMed ID: 17804554
[TBL] [Abstract][Full Text] [Related]
15. [The value of antimitochondrial antibody and its subtypes in the diagnosis of primary biliary cirrhosis].
Yao DK; Xie WF; Chen WZ; Liu HY; Tu XQ; Fan LY
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):9-11. PubMed ID: 15670482
[TBL] [Abstract][Full Text] [Related]
16. Markers of cell activation and apoptosis in bone marrow mononuclear cells of patients with autoimmune hepatitis type 1 and primary biliary cirrhosis.
Tsikrikoni A; Kyriakou DS; Rigopoulou EI; Alexandrakis MG; Zachou K; Passam F; Dalekos GN
J Hepatol; 2005 Mar; 42(3):393-9. PubMed ID: 15710223
[TBL] [Abstract][Full Text] [Related]
17. The role of CXCR3 in the induction of primary biliary cirrhosis.
Zhang W; Fei Y; Gao J; Liu B; Zhang F
Clin Dev Immunol; 2011; 2011():564062. PubMed ID: 21647407
[TBL] [Abstract][Full Text] [Related]
18. Detection of autoantibody against carbonic anhydrase II in various liver diseases by enzyme-linked immunosorbent assay using appropriate conditions.
Hosoda H; Okawa-Takatsuji M; Tanaka A; Uwatoko S; Aotsuka S; Hasimoto N; Ozaki Y; Ikeda Y
Clin Chim Acta; 2004 Apr; 342(1-2):71-81. PubMed ID: 15026266
[TBL] [Abstract][Full Text] [Related]
19. Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway.
Jiang Q; Wei H; Tian Z
BMC Cancer; 2008 Jan; 8():12. PubMed ID: 18199340
[TBL] [Abstract][Full Text] [Related]
20. A novel and effective approach of developing aggressive experimental autoimmune gastritis in neonatal thymectomized BALB/c mouse by polyinosinic:polycytidylic acid.
Kobayashi Y; Murakami H; Akbar SM; Matsui H; Onji M
Clin Exp Immunol; 2004 Jun; 136(3):423-31. PubMed ID: 15147343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
